Yüklüyor......
Systematic drug screening identifies tractable targeted combination therapies in triple-negative breast cancer
Triple-negative breast cancer (TNBC) remains an aggressive disease without effective targeted therapies. In this study, we addressed this challenge by testing 128 FDA-approved or investigational drugs as either single agents or in 768 pairwise drug combinations in TNBC cell lines to identify synergi...
Kaydedildi:
| Yayımlandı: | Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5582957/ https://ncbi.nlm.nih.gov/pubmed/27872098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-1901 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|